Literature DB >> 10358700

Safety, efficacy, and acceptability of home intravenous therapy administered by parents of pediatric oncology patients.

L Hooker1, J Kohler.   

Abstract

BACKGROUND: A prospective study of patients receiving intravenous therapy administered at home by parents was conducted over 1 year at a United Kingdom regional pediatric oncology center. PROCEDURE: The study defined the patient groups for whom this approach was used and evaluated the safety and efficacy of home treatment. Parents' evaluation of home therapy was sought to determine the acceptability of the scheme from their perspective. Eight-nine courses of antibiotics, chemotherapy or antiemetics were given, comprising a total of 469 days of home treatment.
RESULTS: Few clinical problems were encountered. Parents felt that home treatment helped them to cope (72%); they felt more in control (75%) and learned more about their child's illness and treatment (82%).
CONCLUSIONS: Home treatment was perceived as less stressful than hospital treatment (79%), and all reported benefits to family life. There is a need for parents to be taught vigilance in observing for and reporting signs of deterioration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358700     DOI: 10.1002/(sici)1096-911x(199906)32:6<421::aid-mpo5>3.0.co;2-d

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

1.  Home delivery: chemotherapy and pizza?

Authors:  A M Young; D J Kerr
Journal:  BMJ       Date:  2001-04-07

2.  Pediatric Cancer CareLink--supporting home management of childhood leukemia.

Authors:  D M Goldsmith; L B Silverman; C Safran
Journal:  Proc AMIA Symp       Date:  2002

3.  The Hospital at Home program: no place like home.

Authors:  M Lippert; S Semmens; L Tacey; T Rent; K Defoe; M Bucsis; T Shykula; J Crysdale; V Lewis; D Strother; L Lafay-Cousin
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

4.  Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies.

Authors:  François Lüthi; Nadia Fucina; Nathalie Divorne; Brigitte Santos-Eggimann; Christine Currat-Zweifel; Patricia Rollier; Jean-Blaise Wasserfallen; Nicolas Ketterer; Serge Leyvraz
Journal:  Support Care Cancer       Date:  2011-03-08       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.